CLARK IAN T 4
4 · Guardant Health, Inc. · Filed May 22, 2026
Research Summary
AI-generated summary of this filing
Guardant Health (GH) Director Ian T. Clark Sells 6,876 Shares
What Happened
Ian T. Clark, a director of Guardant Health (GH), disposed of 6,876 shares in open‑market transactions on May 20, 2026. The filing reports a weighted‑average sale price of $106.90 per share, for aggregate proceeds of approximately $735,049. This transaction is reported as a sale (code S).
Key Details
- Transaction date: 2026-05-20 (reported on Form 4 filed 2026-05-22).
- Transaction type: Open‑market sale (S), executed in multiple trades.
- Price range: $106.85 to $106.99; weighted average $106.90 (footnote F1).
- Shares sold: 6,876; proceeds ≈ $735,049.
- Shares owned after transaction: Not specified in the provided filing.
- Footnote F1: Indicates the sale occurred in multiple transactions and the reporting person can provide a breakdown of how many shares were sold at each separate price within the stated range upon request.
- Filing timeliness: Filed two days after the trade (appears timely for a Form 4).
Context
This was a straightforward open‑market sale, not an option exercise, award, or gift. Sales by insiders are relatively common for liquidity, diversification, or tax purposes and do not by themselves prove company prospects have changed. Purchases generally carry more weight when interpreting insider conviction; this filing documents a routine liquidation.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-05-20$106.90/sh−6,876$735,049→ 2,975 total(indirect: By Trust)
Footnotes (1)
- [F1]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.85 to $106.99. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.